Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Faculty of Movement and Rehabilitation Sciences, Department of Rehabilitation Sciences, Research Group for Cardiovascular and Respiratory Rehabilitation, KU Leuven - University of Leuven, Leuven, Belgium.
J Neuromuscul Dis. 2023;10(5):825-834. doi: 10.3233/JND-221665.
Respiratory muscle weakness is a common feature in nemaline myopathy. Inspiratory muscle training (IMT) is an intervention that aims to improve inspiratory muscle strength.
The aim of this controlled before-and-after pilot study was to investigate if IMT improves respiratory muscle strength in patients with nemaline myopathy.
Nine patients (7 females; 2 males, age 36.6±20.5 years) with respiratory muscle weakness and different clinical phenotypes and genotypes were included. Patients performed eight weeks of sham IMT followed by eight weeks of active threshold IMT. The patients trained twice a day five days a week for 15 minutes at home. The intensity was constant during the training after a gradual increase to 30% of maximal inspiratory pressure (MIP).
Active IMT significantly improved MIP from 43±15.9 to 47±16.6 cmH2O (p = 0.019). The effect size was 1.22. There was no significant effect of sham IMT. Sniff nasal inspiratory pressure, maximal expiratory pressure, spirometry, and diaphragm thickness and thickening showed no significant improvements.
This pilot study shows that threshold IMT is feasible in patients with nemaline myopathy and improves inspiratory muscle strength. Our findings provide valuable preliminary data for the design of a larger, more comprehensive trial.
呼吸肌无力是杆状体肌病的一个常见特征。吸气肌训练(IMT)是一种旨在提高吸气肌力量的干预措施。
本对照前后先导研究的目的是探讨 IMT 是否能改善杆状体肌病患者的呼吸肌力量。
纳入 9 名(7 名女性;2 名男性,年龄 36.6±20.5 岁)存在呼吸肌无力且具有不同临床表型和基因型的患者。患者先接受 8 周的假 IMT,然后再接受 8 周的主动阈 IMT。患者在家中每天训练两次,每周训练 5 天,每次 15 分钟。训练强度在逐渐增加到最大吸气压力(MIP)的 30%后保持恒定。
主动 IMT 显著提高了 MIP,从 43±15.9cmH2O 提高到 47±16.6cmH2O(p=0.019)。效应大小为 1.22。假 IMT 没有显著效果。嗅吸鼻吸气压力、最大呼气压力、肺活量、膈肌厚度和增厚均无显著改善。
这项先导研究表明,阈 IMT 对杆状体肌病患者是可行的,并且可以提高吸气肌力量。我们的发现为设计更大、更全面的试验提供了有价值的初步数据。